CanSERV
HORIZON Research and Innovation Actions
01/09/2022 – 31/08/2025 (3 years)
Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC)
VIEW PARTNERS >Arttic Innovation GMBH, Germany
Biobanks And Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC), Austria
Centre International De Recherche Sur Le Cancer, France
EATRIS ERIC, Netherlands
ECRIN European Clinical Research Infrastructure Network, France
EURO-BIOIMAGING ERIC, Finland
European Infrastructure Of Open Screening Platforms For Chemical Biology European Research Infrastucture Consortium (EU-OPENSCREEN ERIC), Germany
European Marine Biological Resource Centre European Research Infrastructure Consortium, France
European Molecular Biology Laboratory, Germany
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL, Belgium
Fundacio Privada Institut D’investigacio Oncologica De Vall-Hebron (VHIO), Spain
INFRAFRONTIER GMBH, Germany
INSTRUCT-ERIC, United Kingdom
The University of Manchester, United Kingdom
TTOPSTART BV, Netherlands
Universidade Do Minho, Portugal
Universita Degli Studi Di Torino, Italy
Wageningen University, Netherlands
Why it matters
CanSERV will offer key state-of-the-art RI services necessary to tackle all aspects and challenges of the development pipeline for oncology, as well as the translation to the clinic – from bench to bedside and back to bench- and the engagement with future users.
What ECPC does
ECPC will play a key role in this project, contributing to address social inequalities around Europe, promoting the access to cutting-edge services and tool-kits to better inform patients about public health measures and the accessibility to new advances in cancer research.
This project has received funding from the European Union’s Horizon Europe Coordination and Support Actions programme under grant agreement No 101058620